Likewise, mouse models for malaria, trypanosomiasis or cryptococcus infection have shown that a single treatment with α-GalCer rapidly stimulated IFN-γ production by iNKT cells and reduced parasite and bacterial burden, respectively [19],[35],[36]. Here, IFNG is linked to trypanosomiasis.